May 20, 2026 Dyne Therapeutics Announces Initiation of Phase 3 FORZETTO Trial of Z-Rostudirsen in Duchenne Muscular Dystrophy (DMD) Ahead of Planned BLA Submission for U.S. Accelerated Approval
May 20, 2026 The National Association of Special Education Teachers (NASET) Announces Its 2026 Schools of Excellence and Exceptional Charter Schools